Get started
Author

Sean W. X. Ong

Randomized Clinical Trials Using a Hierarchical Composite Primary End Point
2026 · Selina Ehrenzeller, Amos J. de Jong, et al. · JAMA Network Open · 1
Reporting of geriatric participant characteristics and inclusion of older adults in infectious diseases clinical trials: a secondary analysis of a systematic review
2026 · Christina Blagojevic, Aliya Bryce, et al. · Clinical Microbiology and Infection · 1
Duration of Therapy for Pseudomonas aeruginosa Bacteremia—A Post Hoc Subgroup Analysis From the BALANCE Randomized Controlled Trial
2026 · Dafna Yahav, Ruxandra Pinto, et al. · Clinical Infectious Diseases · 1
Shorter versus longer durations of antibiotic treatment for pneumonia in dogs and cats: a systematic review and meta-analysis
2026 · Fiona Emdin, Abby Emdin, et al. · Journal of the American Veterinary Medical Association · 1
Clinical and regulatory acceptability of hierarchical composite endpoints in infectious disease clinical trials
2026 · Amos J. de Jong, Daphne S.A. Bennink, et al. · Clinical Microbiology and Infection
PDF
Primer for Clinical Researchers on Ordinal Outcomes for Emergency Medicine
2026 · Chris J. Selman, Sean W. X. Ong, et al. · Emergency Medicine Australasia
Association Between β-Lactam Exposure and Clearance of Bacteremia and Acute Kidney Injury in Patients with Meticillin-Resistant Staphylococcus aureus Bloodstream Infections – A Post Hoc Analysis of the CAMERA2 Trial
2026 · Neta Petersiel, Amy Legg, et al. · SSRN Electronic Journal
Do’s and DOTS: contextualizing a clinical trial evaluating dalbavancin use in Staphylococcus aureus bacteraemia
2025 · Jonas Tverring, Sean W.X. Ong · CMI Communications
PDF
Works count: 8
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type